These dietary interventions regulate immune function by decreasing the secretion of interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), leptin, and interleukin-6 (IL-6), while elevating concentrations of IL-10, thereby reducing inflammation, demyelination, and MS-related axonal lesions. Here, IFNG is linked to myeloid sarcoma.